In vitro analysis of tantalum-containing mesoporous bioactive glass fibres for haemostasis.

Q3 Engineering
Malvika Nagrath, Alireza Rahimnejad Yazdi, Daniella Marx, Tiffany Ni, Reid C Gallant, Heyu Ni, Mark R Towler
{"title":"<i>In vitro</i> analysis of tantalum-containing mesoporous bioactive glass fibres for haemostasis.","authors":"Malvika Nagrath, Alireza Rahimnejad Yazdi, Daniella Marx, Tiffany Ni, Reid C Gallant, Heyu Ni, Mark R Towler","doi":"10.1080/03091902.2024.2356618","DOIUrl":null,"url":null,"abstract":"<p><p>Haemorrhage is the leading cause of battlefield deaths and second most common cause for civilian mortality worldwide. Biomaterials-based haemostatic agents are used to aid in bleeding stoppage; mesoporous bioactive glasses (MBGs) are candidates for haemostasis. Previously made Tantalum-containing MBG (Ta-MBG) powders' compositions were fabricated as electrospun <i>fibres</i> for haemostatic applications in the present study. The fibres were fabricated to address the challenges associated with the powder form: difficult to compress without gauze, getting washed away in profuse bleeding, generating dust in the surgical environment, and forming thick callus-difficult to remove for surgeons and painful for patients. Ta-MBGs were based on (80-<i>x</i>)SiO<sub>2</sub>-15CaO-5P<sub>2</sub>O<sub>5</sub>-<i>x</i>Ta<sub>2</sub>O<sub>5</sub> mol% compositions with <i>x</i> = 0 (0Ta), 0.5 (0.5Ta), 1 (1Ta), and 5 (5Ta) mol%. The present study details the fibres' <i>in vitro</i> analyses, elucidating their cytotoxic effects, and haemostatic capabilities and relating these observations to fibre chemistry and previously fabricated powders of the same glasses. As expected, when Ta addition is increased at the expense of silica, a new FTIR peak (non-bridging oxygen-silicon, Si-NBO) develops and Si-O-Si peaks become wider. Compared to 0Ta and 1Ta fibres, 0.5Ta show Si-O peaks with reduced intensity. The fibres had a weaker intensity of Si-NBO peaks and release fewer ions than powders. A reduced ion profile provides fibres with a stable matrix for clot formation. The ion release profile for 1Ta and 5Ta fibres was significantly lower than 0Ta and 0.5Ta fibres. Ta-MBGs were not found to be cytotoxic to primary rat fibroblasts using a methyl thiazolyl tetrazolium (MTT) assay. Furthermore, a modified activated partial thromboplastin time assay analysing the fibrin absorbance showed that the absorption increases from physiological clotting < 0Ta < 0.5Ta < 5Ta < commercial haemostat, Surgical SNoW<sup>TM</sup>, Ethicon, USA < 1Ta. Higher absorption signifies a stronger clot. It is concluded that Ta-MBG fibres can provide stable matrix for clot formation and 1Ta can potentially enhance clotting best among other Ta-MBGs.</p>","PeriodicalId":39637,"journal":{"name":"Journal of Medical Engineering and Technology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Medical Engineering and Technology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/03091902.2024.2356618","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/6/10 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"Engineering","Score":null,"Total":0}
引用次数: 0

Abstract

Haemorrhage is the leading cause of battlefield deaths and second most common cause for civilian mortality worldwide. Biomaterials-based haemostatic agents are used to aid in bleeding stoppage; mesoporous bioactive glasses (MBGs) are candidates for haemostasis. Previously made Tantalum-containing MBG (Ta-MBG) powders' compositions were fabricated as electrospun fibres for haemostatic applications in the present study. The fibres were fabricated to address the challenges associated with the powder form: difficult to compress without gauze, getting washed away in profuse bleeding, generating dust in the surgical environment, and forming thick callus-difficult to remove for surgeons and painful for patients. Ta-MBGs were based on (80-x)SiO2-15CaO-5P2O5-xTa2O5 mol% compositions with x = 0 (0Ta), 0.5 (0.5Ta), 1 (1Ta), and 5 (5Ta) mol%. The present study details the fibres' in vitro analyses, elucidating their cytotoxic effects, and haemostatic capabilities and relating these observations to fibre chemistry and previously fabricated powders of the same glasses. As expected, when Ta addition is increased at the expense of silica, a new FTIR peak (non-bridging oxygen-silicon, Si-NBO) develops and Si-O-Si peaks become wider. Compared to 0Ta and 1Ta fibres, 0.5Ta show Si-O peaks with reduced intensity. The fibres had a weaker intensity of Si-NBO peaks and release fewer ions than powders. A reduced ion profile provides fibres with a stable matrix for clot formation. The ion release profile for 1Ta and 5Ta fibres was significantly lower than 0Ta and 0.5Ta fibres. Ta-MBGs were not found to be cytotoxic to primary rat fibroblasts using a methyl thiazolyl tetrazolium (MTT) assay. Furthermore, a modified activated partial thromboplastin time assay analysing the fibrin absorbance showed that the absorption increases from physiological clotting < 0Ta < 0.5Ta < 5Ta < commercial haemostat, Surgical SNoWTM, Ethicon, USA < 1Ta. Higher absorption signifies a stronger clot. It is concluded that Ta-MBG fibres can provide stable matrix for clot formation and 1Ta can potentially enhance clotting best among other Ta-MBGs.

用于止血的含钽介孔生物活性玻璃纤维的体外分析。
大出血是战场死亡的主要原因,也是全球平民死亡的第二大原因。基于生物材料的止血剂可用于帮助止血;介孔生物活性玻璃 (MBG) 是止血的候选材料。本研究将以前制成的含钽介孔生物活性玻璃(Ta-MBG)粉末成分制成电纺纤维,用于止血。制造这种纤维是为了解决与粉末形式相关的难题:在没有纱布的情况下难以压迫,在大量出血时被冲走,在手术环境中产生灰尘,以及形成厚茧--外科医生难以去除,病人痛苦不堪。Ta-MBG 基于 (80-x)SiO2-15CaO-5P2O5-xTa2O5 mol% 的成分,其中 x = 0(0Ta)、0.5(0.5Ta)、1(1Ta)和 5(5Ta) mol%。本研究详细介绍了这些纤维的体外分析,阐明了它们的细胞毒性作用和止血能力,并将这些观察结果与纤维化学和以前制造的相同玻璃粉末联系起来。正如所预期的那样,当钽的添加量增加而二氧化硅的添加量减少时,会出现一个新的傅立叶变换红外峰(非桥接氧-硅,Si-NBO),Si-O-Si 峰变得更宽。与 0Ta 和 1Ta 纤维相比,0.5Ta 纤维的 Si-O 峰强度降低。与粉末相比,纤维的 Si-NBO 峰强度更弱,释放的离子更少。离子分布的减少为纤维提供了形成凝块的稳定基质。1Ta 和 5Ta 纤维的离子释放曲线明显低于 0Ta 和 0.5Ta 纤维。使用甲基噻唑四唑(MTT)检测法发现,Ta-MBG 对原代大鼠成纤维细胞没有细胞毒性。此外,通过分析纤维蛋白吸光度的改良活化部分凝血活酶时间测定显示,从生理凝血 < 0Ta < 0.5Ta < 5Ta TM(美国 Ethicon 公司) < 1Ta 开始,吸光度不断增加。吸收率越高,说明凝块越牢固。由此得出结论,Ta-MBG 纤维能为凝块的形成提供稳定的基质,而 1Ta 有可能是其他 Ta-MBG 中增强凝块效果最好的一种。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Medical Engineering and Technology
Journal of Medical Engineering and Technology Engineering-Biomedical Engineering
CiteScore
4.60
自引率
0.00%
发文量
77
期刊介绍: The Journal of Medical Engineering & Technology is an international, independent, multidisciplinary, bimonthly journal promoting an understanding of the physiological processes underlying disease processes and the appropriate application of technology. Features include authoritative review papers, the reporting of original research, and evaluation reports on new and existing techniques and devices. Each issue of the journal contains a comprehensive information service which provides news relevant to the world of medical technology, details of new products, book reviews, and selected contents of related journals.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信